rs61752068
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The NM_000330.4(RS1):c.305G>A(p.Arg102Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000827 in 1,208,809 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R102W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.305G>A | p.Arg102Gln | missense_variant | 4/6 | ENST00000379984.4 | |
RS1 | XM_047442337.1 | c.209G>A | p.Arg70Gln | missense_variant | 2/4 | ||
CDKL5 | NM_001037343.2 | c.2797+1122C>T | intron_variant | ||||
CDKL5 | NM_003159.3 | c.2797+1122C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.305G>A | p.Arg102Gln | missense_variant | 4/6 | 1 | NM_000330.4 | P1 | |
CDKL5 | ENST00000379989.6 | c.2797+1122C>T | intron_variant | 1 | |||||
CDKL5 | ENST00000379996.7 | c.2797+1122C>T | intron_variant | 1 | |||||
RS1 | ENST00000476595.1 | n.796G>A | non_coding_transcript_exon_variant | 3/5 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.00000902 AC: 1AN: 110807Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32995
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183304Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67740
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1098002Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 363402
GnomAD4 genome ? AF: 0.00000902 AC: 1AN: 110807Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32995
ClinVar
Submissions by phenotype
Juvenile retinoschisis Pathogenic:5
Pathogenic, no assertion criteria provided | literature only | Counsyl | May 06, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.98; 3Cnet: 0.86). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009896). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 17615541, 21701876, 24634885, 30652005). A different missense change at the same codon (p.Arg102Trp) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009887). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 24, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 15, 2007 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 06, 2023 | - - |
not provided Pathogenic:3Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 102 of the RS1 protein (p.Arg102Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked retinoschisis (PMID: 9618178, 17615541, 30652005). ClinVar contains an entry for this variant (Variation ID: 9896). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg102 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9618178, 24634885, 30652005). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2022 | RS1: PM2, PM5, PM6, PS4:Moderate, PP1, PP4, PS3:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 04, 2023 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Molecular modeling of the R102 position predicts a severe change which could affect the protein fold and thus is likely damaging to the protein structure/function (Sergeev et al., 2010); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9618178, 26894784, 28272453, 28348004, 34624300, 32531858, 35456481, 34828422, 17304551, 30652005, 31006083, 32783370, 34822951, 35309139, 34798543, 20061330) - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jun 29, 2019 | - - |
RS1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 07, 2023 | The RS1 c.305G>A variant is predicted to result in the amino acid substitution p.Arg102Gln. This variant has been reported as causative for X-linked juvenile retinoschisis, XLRS (see for example RSC et al. 1998. PubMed ID: 9618178; Kondo et al. 2019. PubMed ID: 30652005). Additionally, a different substitution of the same amino acid (p.Arg102Trp) has been reported as causative for XLRS (Vijayasarathy et al. 2010. PubMed ID: 20809529; Kondo et al. 2019. PubMed ID: 30652005). This variant is reported in 0.0012% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/X-18665332-C-T). This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/9896). Given all the evidence, we interpret c.305G>A (p.Arg201Gln) as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at